INDIRECT COMPARISIONS PRESENTED IN GERMAN BENEFIT ASSESSMENTS - STATUS QUO AND QUO VADIS?

被引:0
|
作者
Kreisor, M. [1 ]
Schiffter-Weinle, H. A. [1 ]
Boehler, Y. [1 ]
机构
[1] Univ Appl Sci, TH Koeln, Leverkusen, Germany
关键词
D O I
10.1016/j.jval.2017.08.1778
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP242
引用
收藏
页码:A694 / A694
页数:1
相关论文
共 50 条
  • [31] PATIENT-FOCUSED OUTCOMES IN THE AMNOG-PROCESS - STATUS QUO AND QUO VADIS
    Wilmes, R.
    Schiffter-Weinle, H. A.
    Boehler, Y. B.
    VALUE IN HEALTH, 2019, 22 : S722 - S722
  • [32] Improving residency programs in urology: status quo et quo vadis Future perspectives
    Neutzer, Maike
    Heidenreich, Axel
    UROLOGIE, 2025,
  • [33] QUO VADIS, STRUCTURAL POLICIES - GERMAN - DORGE,FW
    DEDERRA, E
    POLITISCHE STUDIEN, 1970, 21 (190) : 228 - +
  • [34] Transforming German workplace relations: Quo vadis cooperation?
    Frege, CM
    ECONOMIC AND INDUSTRIAL DEMOCRACY, 2003, 24 (03) : 317 - 347
  • [35] Access and benefit sharing under the Nagoya Protocol - Quo Vadis?
    Carmenza, Spadafora
    Michael, Heinrich
    PLANTA MEDICA, 2021, 87 (15) : 1237 - 1237
  • [36] Quo vadis dermatology?: From a German perspective, cloudy
    Happle, R
    ARCHIVES OF DERMATOLOGY, 2000, 136 (01) : 50 - 51
  • [37] Disclosure of potential conflicts of interest in dermatological guidelines in Germany - an analysis - status quo and quo vadis
    Rosumeck, Stefanie
    Sporbeck, Birte
    Rzany, Berthold
    Nast, Alexander
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (04): : 297 - 303
  • [38] Use of whole genome sequencing for surveillance and control of foodborne diseases: status quo and quo vadis
    Schadron, Tristan
    van den Beld, Maaike
    Mughini-Gras, Lapo
    Franz, Eelco
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [39] QUO-VADIS WEST-GERMAN PSYCHIATRY REFORM
    KEUPP, H
    GRUPPENPSYCHOTHERAPIE UND GRUPPENDYNAMIK, 1990, 26 (01) : 68 - 80
  • [40] QUO VADIS BENEFIT ASSESSMENT FOR ORPHAN DRUGS IN GERMANY: THE END OF THE EXCEPTION?
    Weiner, L.
    Khonsari, R.
    Walzer, S.
    VALUE IN HEALTH, 2022, 25 (12) : S302 - S302